Trial site
Gottsegen National Cardiovascular Center
- 21running trials
- 10closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Heart failure11 trials
- High blood pressure11 trials
- Pulmonary arterial hypertension10 trials
- Coronary artery disease3 trials
- Amyloidosis1 trial
- Aortic stenosis1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Hypertrophic cardiomyopathy1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 317 trials
- Phase 25 trials
- Phase 43 trials
- Phase 2/31 trial
- Status
- Recruiting13 trials
- Completed10 trials
- Active, not recruiting6 trials
- Not yet recruiting2 trials
- Lead sponsor
- Merck Sharp & Dohme LLC5 trials
- Actelion4 trials
- Boehringer Ingelheim3 trials
- AOP Orphan Pharmaceuticals AG2 trials
- Bayer2 trials
- and 13 more
Running trials
Not yet recruiting
A study to compare heart failure medicines in one combined pill with usual care.
Recruiting
Recruiting
Recruiting
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
Active, not recruiting
Recruiting
Recruiting
Recruiting
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure7 recruiting
- High blood pressure4 recruiting
- Pulmonary arterial hypertension3 recruiting
- Amyloidosis1 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Not yet recruiting
Completed
Completed
Completed
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026